Medartis Holding AGXSWX:MED -0.55%76 FCF Yield % is 1.05 as of Jun. 25, 2026, which is 775% above its 10-year median of 0.12. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.61 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Medartis Holding AG ranks better than 60.12% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medartis Holding AG's FCF Yield % or its related term are showing as below:
XSWX:MED'
s FCF Yield % Range Over the Past 10 Years
Min: -2.94 Med: 0.12 Max: 2.93
Current: 1.05
During the past 12 years, the highest FCF Yield % of Medartis Holding AG was 2.93%. The lowest was -2.94%. And the median was 0.12%.
XSWX:MED's FCF Yield % is ranked better than 60.12% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.37
vs XSWX:MED: 1.05
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medartis Holding AG FCF Yield % Related Terms
Medartis Holding AG FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a FCF Yield % of 1.05 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medartis Holding AG and its competitors. This is 775% above median its historical median of 0.12. According to the industry distribution chart, Medartis Holding AG ranks #341 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 39.9%.
Is Medartis Holding AG's FCF Yield % too high?
Medartis Holding AG's current FCF Yield % of 1.05 is 775% above median its 10-year median of 0.12. Based on the distribution chart, Medartis Holding AG ranks #341 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #341 out of 855 companies for FCF Yield %. This puts Medartis Holding AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current FCF Yield % is 1.05, which is 775% above median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF105.61, compared to a current price of CHF72.00 — trading 31.8% below its estimated fair value. The current FCF Yield % is 1.05, which is 775% above median its 10-year median of 0.12. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current FCF Yield % is 1.05 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF72.00 is trading 31.8% below its estimated GF Value™ of CHF105.61.
GuruFocus considers Medartis Holding AG to be Significantly Undervalued.
Key valuation signals for XSWX:MED:
FCF Yield %: 1.05 (775% above median its 10-year median of 0.12)
GF Value™: CHF105.61 vs. price of CHF72.00 (31.8% below fair value)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score
Get the complete analysis for XSWX:MED
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
